• Cancers, vers une révolution thérapeutique ?, Barbet J, Foucquier A, Thomas Y., 2019.
  • Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”, Eychenne R, Chérel M, Haddad F, Guérard F, Gestin J-F., Pharmaceutics. 18 juin 2021;13(6):906. https://doi.org/10.3390/pharmaceutics13060906
  • Radionuclide candidates for β+γ coincidence PET: An overview, Sitarz M, Cussonneau J-P, Matulewicz T, Haddad F., Applied Radiation and Isotopes. janv 2020;155:108898. https://doi.org/10.1016/j.apradiso.2019.108898

  • Production of polonium from bismuth and purification using TBP resin and Sr resin, Younes A, Alliot C, Ali JS, Bonraisin A-C, Mokili M, Happel S, et al., J Radioanal Nucl Chem. mai 2020;324(2):823‑8. https://doi.org/10.1007/s10967-020-07109-5

  • CERN-MEDICIS: a unique facility for the production of nonconventional radionuclides for the medical research, Duchemin C, Ramos JP, Stora T, Aubert E, Audouin N, Barbero E, et al., In: 11th International Particle Accelerator Conference [Internet]. Caen, France; 2020.
    Disponible sur: https://hal.archives-ouvertes.fr/hal-03013154

  • Nanomedicine for Nuclear Imaging and drug delivery: what needs of characterization for what challenges?, S. Huclier, 22 Novembre 2019, Colorado Schools of Mines, Golden (Colorado, USA)

  • Theranostic Radiopharmaceuticals : at the Inflection Point, Jean-François Chatal, Françoise Bodere-Kraeber, Caroline Rousseau, Ferid Haddad, British Journal of Cancer Research, 2019, 2 (2), pp.264-269.

  • Very high specific activity erbium 169Er production for potential receptor-targeted radiotherapy, Formento-Cavaier R, Köster U, Crepieux B, Gadelshin VM, Haddad F, Stora T, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:468‑71. https://doi.org/10.1016/j.nimb.2019.04.022

  • MELISSA : Laser ion source setup at CERN-MEDICIS facility. Blueprint, Gadelshin VM, Barozier V, Cocolios TE, Fedosseev VN, Formento-Cavaier R, Haddad F, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:460‑3. https://doi.org/10.1016/j.nimb.2019.04.024

  • Arronax a facility to produce nonstandard radionuclides and radiopharmaceuticals. 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018